Best Biopharma Outsourcing Companies in North Carolina, United States
The 146 best Biopharma Outsourcing companies in North Carolina, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: PPD.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in North Carolina
| # | Company | Disclosed funding | Last round | Employees | Founded | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|
| 1 | PPD CRO providing diversified clinical development services 87Funding top 18%Fin. health top 19%Market top 23%Moat top 34% All 8 signals ▾Fundingtop 18% Fin. healthtop 19% Markettop 23% Moattop 34% Techtop 38% Growthbottom 48% Globalbottom 46% Newsbottom 35% Funding: Raised $1.0B across 5 rounds · 5 rounds over 3 yrs (1.7/yr) Fin. health: Revenue ~$4.7B (FY2021) · Net margin 10.7% rank vs industry peers · Fliar Intelligence Index 87/100 | $1.0B | 32 mo ago | 1,530 | 1985 | — | — |
| 2 | Caidya CRO focused on clinical development for phases II & III clinical trials and regulatory affair services 50Funding top 20%Tech top 48%Growth bottom 45%Market bottom 44% All 7 signals ▾Fundingtop 20% Techtop 48% Growthbottom 45% Marketbottom 44% Moatbottom 38% Globalbottom 37% Newsbottom 21% Funding: Raised $373M across 5 rounds · 5 rounds over 10 yrs (0.5/yr) Tech: 25 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 50/100 | $373M | 17 mo ago | 351 351 → 748 (+113%) | 2003 | — | 1 partnership · 2 awards |
| 3 | Asymchem CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally | $331M | 76 mo ago | 48 | 1995 | — | — |
| 4 | Avista Pharma Leading hosting automation software providing web server and website management tools | $252M | — | 330 | 2015 | — | — |
| 5 | Patheon Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 54 mo ago | 9,000 | 1974 | 10 patents pH‑dependent solid dosage forms for controlled release of ionizable poorly soluble drugs | — |
| 6 | Rho Full and functional service CRO offering clinical development services 57Funding top 35%Growth top 35%News top 40%Tech top 45% All 7 signals ▾Fundingtop 35% Growthtop 35% Newstop 40% Techtop 45% Markettop 49% Globalbottom 37% Productbottom 36% Funding: Raised $67.5M across 9 rounds · 9 rounds over 12 yrs (0.8/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 57/100 | $67M | 13 mo ago | 859 | 1984 | — | — |
| 7 | Centice Computational sensor technology | $52M | 146 mo ago | 12 | 2004 | — | — |
| 8 | Humaneva Group Provider of clinical research data services for oncology & other therapeutic areas | $50M | 20 mo ago | — | 2014 | — | — |
| 9 | Javara Research Integrating clinical research at the point of care for better outcomes 50Funding top 31%Growth top 35%Tech top 43%Moat top 48% All 8 signals ▾Fundingtop 31% Growthtop 35% Techtop 43% Moattop 48% Talentbottom 49% Marketbottom 41% Globalbottom 29% Newsbottom 21% Funding: Raised $40.0M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 50/100 | $40M | 13 mo ago | 233 | 2018 | — | 1 award |
| 10 | Inceptor CDMO offering services for cell and gene therapy products 7Funding top 47%Moat bottom 42%Global bottom 35%Market bottom 34% All 7 signals ▾Fundingtop 47% Moatbottom 42% Globalbottom 35% Marketbottom 34% Patentsbottom 31% Newsbottom 21% Innovationbottom 4% Funding: Raised $37.7M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) Moat: Editorial + unicorn rating 1/10 · IP moat: 2 patents rank vs industry peers · Fliar Intelligence Index 7/100 | $38M | 17 mo ago | 69 | 2020 | 2 patents Accelerating web page delivery and enriching data indexing for e‑commerce platforms | — |
| 11 | KBI Biopharma Provider of protein formulation, process & cell line development, and cGMP services | $21M | 202 mo ago | 1,243 1,243 → 1,686 (+36%) | 1996 | 24 patents Non‑chromatographic protein purification using steric exclusion and charge neutralization; fluidized‑bed particle processing. | 1 launch · 1 partnership |
| 12 | NightHawk Biosciences Fully integrated biopharmaceutical company | $17M | 33 mo ago | 29 | 2008 | — | — |
| 13 | Cutting Edge Info Research reports and data provider for pharmaceutical and life science industries | $16M | 227 mo ago | 25 | 2002 | — | — |
| 14 | Inclinix Customized clinical trial enrollment solution | $10M | 188 mo ago | 75 | 1999 | — | — |
| 15 | Zen-Bio Cell-based solutions for drug discovery, research, and cosmetic development | $10M | 177 mo ago | 21 | 1995 | — | — |
| 16 | Ntouch Research Full service CRO | $9M | 316 mo ago | — | 1997 | — | — |
| 17 | Isolere Bio Developer of bioprocessing reagents for purification and manufacturing of therapeutics | $7M | 52 mo ago | 18 | 2017 | — | — |
| 18 | Exela Pharma Manufacturer of sterile injectable pharmaceutical products and CDMO services 48Innovation top 20%Product top 30%Growth top 40%Funding top 43% All 8 signals ▾Innovationtop 20% Producttop 30% Growthtop 40% Fundingtop 43% Talentbottom 49% Marketbottom 37% Globalbottom 32% Techbottom 31% Innovation: 8 product lines Product: 8 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 48/100 | $7M | 8 mo ago | 205 205 → 339 (+65%) | 2005 | — | 2 job openings · 1 award |
| 19 | QATCH Technologies CRO focused on providing early stage drug development services | $6M | 15 mo ago | 6 | 2016 | — | 1 launch |
| 20 | Clinical Trial Research Network of research sites providing clinical trial management services 29Funding top 41%Talent bottom 49%Global bottom 33% All 3 signals ▾Fundingtop 41% Talentbottom 49% Globalbottom 33% Funding: Raised $5.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 29/100 | $5M | 6 mo ago | — | 2025 | — | — |
| 21 | ILS Provider of clinical research and regulatory services | $5M | 142 mo ago | 100 | 1985 | — | — |
| 22 | INC Research Global CRO providing the full range of Phase I-IV clinical development services | $5M | 102 mo ago | 6,700 | 1998 | — | — |
| 23 | AlphaVax RNA particle vaccine technology company developing anti-infective and anti-cancer vaccines | $3M | 193 mo ago | 9 | 1997 | 159 patents Production of alphavirus replicon particles for vaccine and gene‑therapy vectors | — |
| 24 | Lamassu Pharma Provider of market research and clinical development & testing services | $3M | 27 mo ago | 3 | 2018 | — | — |
| 25 | PRA Health Sciences Global full-service CRO offering its services in 80+ countries globally | $2M | — | 12,870 | 1976 | — | — |
| 26 | Path Bioanalytics Developing a cloud-based software for assays | $2M | 74 mo ago | 2 | 2015 | — | — |
| 27 | Health Decisions CRO focused on clinical trial services for data management, monitoring and biostatistics | $2M | 97 mo ago | 110 | 1989 | — | — |
| 28 | Wright Avenue Partners Provider of functional service for clinical development | $2M | 119 mo ago | — | 2015 | — | — |
| 29 | Sciome Provider of software development services for biopharma sector | $2M | 33 mo ago | — | 2010 | 9 patents AI-driven text extraction from unstructured documents and recall estimation for systematic reviews | — |
| 30 | Allucent Provider of drug development consulting, data management, programming, and health services | $1M | 90 mo ago | 1,406 | 1994 | — | — |
| 31 | VeraSci Provider of data management and site selection services | $1M | 118 mo ago | 181 | 2016 | — | — |
| 32 | BioLink Life Sciences cGMP compliant analytical testing laboratory offering drug development solutions | $676K | 168 mo ago | 24 | 2001 | — | — |
| 33 | Kryosphere Provider of storage, logistics, validation, and disposal services | $400K | 192 mo ago | 38 | 2007 | — | — |
| 34 | ArrayXpress Provider of bioprocess optimization and genomics services for pharmaceutical, medical, and agricultural… | $300K | 222 mo ago | 12 | 2002 | — | — |
| 35 | Premier Research Provider of clinical trial CRO services | $200K | 116 mo ago | 1,029 | 1989 | — | — |
| 36 | Vector Psychometric Group Provider of qualitative, statistical, and other consulting services | $165K | 201 mo ago | 11 | 2007 | — | — |
| 37 | BMI OrganBank Company developing groundbreaking new organ and tissue perfusion technology to preserve and sustain organs | $100K | 27 mo ago | 6 | 2005 | — | 1 award |
| 38 | Pulmonix Provider of clinical trial services | $97K | 130 mo ago | 8 | 2015 | — | — |
| 39 | CliniSpan Health CRO focused on providing patient recruitment services | $20K | 24 mo ago | 9 | 2018 | — | — |
| 40 | LabCorp Provider of laboratory tests for physicians | — | 16 mo ago | 9,321 | 1969 | — | — |
Top 12 Biopharma Outsourcing companies in North Carolina
#1
Series C · Morrisville, North Carolina · founded 2003 · 351 employees$373Mraised▾
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
- Jan 2025PE$165M
- Jul 2021Series C$50M
- Dec 2020Series C$100M
- Oct 2019Series B$50M
#2
Funding Raised · Chapel Hill, North Carolina · founded 1984 · 859 employees$67.5Mraised▾
Rho offers contract research services for Phase I - IV trials, post-approval phases, regulatory submissions, and trial rescue. They use the proprietary platforms of Medidata, Oracle, and Medrio for clinical trial management. Their clinical trial service portfolio includes Biostatistics and Statistical Programming, Clinical Data Management, Clinical Operations and Monitoring, Clinical Project Management, Data Standards, Medical Monitoring, Product Safety, Quality Assurance, Regulatory Operations, Re and Medical Writing. Therapeutic areas they cater to are ADHD, Analgesia, CNS, Dental, Hematology, Ophthalmology, Psychiatric Disorders, Respiratory. They are currently engaged in over 23 federal projects and have signed contracts for clinical development with various US Federal Agencies. They also offer their services on an FSP basis for biostatistics and statistical programming, data standards and CDISC, Data management, and Regulatory medical writing.
- May 2025Grant (prize money)$28.2M
- Apr 2025Grant (prize money)$28.4M
- Feb 2021Grant (prize money)$368.9K
- Apr 2014Grant (prize money)—
#3
Series B · Winston-salem, North Carolina · founded 2018 · 233 employees$40Mraised▾
Integrating clinical research at the point of care for better outcomes. This organization pioneers Clinical Research as a Care Option (CRAACO), connecting patients with clinical trials through trusted physicians and healthcare partners. The model unlocks access to broader, more diverse populations, driving faster enrollment, stronger retention, and richer data. By streamlining operations and centralizing resources, they aim to reduce the drug development time cycle and improve patient care. As an Integrated Research Organization (IRO), they provide staff, training, and infrastructure needed to conduct clinical trials and drive innovation. They focus on diversity, equity, and inclusion, fostering greater innovation and improving communication and care. The organization partners with biopharma, biotech, and CRO companies to deliver high-quality data from diverse patient populations, enhancing patient care through in-house clinical research. They offer services to healthcare organizations, biopharmaceutical companies, and contract research organizations (CROs).
- May 2025Series B$6.6M
- Nov 2023Conventional Debt$9.4M
- Apr 2022Series B$30M
- Aug 2020Series A$4.6M
#4
Late Stage · Research Triangle Park, North Carolina · founded 2025$5Mraised▾
Network of research sites providing clinical trial management services. The organization offers site management for clinical trials across multiple therapeutic areas. These areas include behavioral health, central nervous system, respiratory, pulmonary, internal medicine, gastrointestinal, nephrology, and ophthalmology. The organization aims to improve clinical trial efficiency through technology and collaboration with healthcare providers.
- Nov 2025PE$5M
#5
Series B · Lenoir, North Carolina · founded 2005 · 205 employees$6.7Mraised▾
Manufacturer of sterile injectable pharmaceutical products and CDMO services. This entity develops and manufactures both proprietary and generic sterile injectables. Its operations encompass the entire pharmaceutical lifecycle, from research and development to finished drug product manufacturing and distribution. Services include contract development and manufacturing, leveraging expertise in liquid vials, IV bags, lyophilized vials, and pre-filled syringes. The company also offers a range of regulatory support services.
- Sep 2025Grant (prize money)$28.3M
- Sep 2021Series B—
- Aug 2015Series A$419.8K
- Jul 2013Conventional Debt$1M
#6
Series A · Raleigh, North Carolina · founded 2020 · 69 employees$37.7Mraised▾
CDMO offering services for cell and gene therapy products
- Jan 2025Series A$21M
- Oct 2022Conventional Debt$15.9M
- Mar 2022Series A$37.7M
#7
Acquired · Wilmington, North Carolina · founded 1985 · 1530 employees$1Braised▾
CRO providing diversified clinical development services
- Oct 2023Grant (prize money)$126.5M
- May 2019Conventional Debt$900M
- Dec 2011PE—
- Aug 2009Grant (prize money)$7.1M
#8
Late Stage · Raleigh, North Carolina · founded 2014$50Mraised▾
Provider of clinical research data services for oncology & other therapeutic areas
- Sep 2024PE$50M
#9
Funding Raised · Durham, North Carolina · founded 2016 · 6 employees$5.6Mraised▾
QATCH Technologies is a life-science instrumentation start-up, and was founded to commercialize a sensor technology developed at Duke University. QATCH is currently developing a tool to prescreen injectability and manufacturability of biopharmaceutical drugs at an early stage of drug development due to the very low volume needed (μLs). QATCH's proprietary technology can de-risk preclinical phase for biopharmaceutical drug development and prevent delays for crucial medicines reaching patients.
- Mar 2025Grant (prize money)$1.5M
- Sep 2023Grant (prize money)$1.9M
- Feb 2022Grant (prize money)$1.5M
- Sep 2020Grant (prize money)$255.7K
#10
Public · Morrisville, North Carolina · founded 2008 · 29 employees$17.3Mraised▾
Fully integrated biopharmaceutical company
- Sep 2023Grant (prize money)$399.1K
- Sep 2023Grant (prize money)$299.4K
- Dec 2022Grant (prize money)$144.2K
- May 2017Post IPO$500K
#11
Acquired · Durham, North Carolina · founded 1974 · 9000 employees$141Mraised▾
Global CDMO providing integrated drug development, clinical trials, and manufacturing services. They offer comprehensive contract development and manufacturing organization (CDMO) and contract research organization (CRO) solutions to accelerate drug development journeys. Their capabilities span small and large molecules, advanced therapies like viral vectors, cell therapy, and mRNA, and steriles. Services include clinical trial services, clinical packaging, labeling, logistics, and commercial services. They focus on innovative solutions, digital enablement, and supply chain strategies for risk mitigation. They provide end-to-end solutions across all phases of development, from early-stage R&D to commercial manufacturing, with a global network of sites and scientific expertise. They aim to simplify and accelerate the journey to market, offering integrated offerings and digital platforms for collaboration and transparency.
#12
Public · Morrisville, North Carolina · founded 1995 · 48 employees$330.6Mraised▾
CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally. It offers services encompassing the entire drug development lifecycle, from early-stage research to commercial manufacturing. The company focuses on delivering innovative and scalable solutions to meet the evolving needs of the pharmaceutical industry. Its expertise includes process development, API manufacturing, formulation development, and clinical trial material production. The company supports global pharma companies with high-quality, compliant, and efficient CDMO services, ensuring the successful development and manufacturing of pharmaceutical products. It leverages advanced technologies and a commitment to excellence to accelerate drug development timelines and improve patient outcomes.
- Feb 2020Post IPO$330.6M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.